TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

PURPOSE: The identification of patients with metastatic triple-negative breast cancer (mTNBC) who are expected to benefit from platinum-based chemotherapy is of interest. We conducted a single-arm phase II clinical trial of single-agent platinum for mTNBC with biomarker correlates. PATIENTS AND METH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Isakoff, Steven J., Mayer, Erica L., He, Lei, Traina, Tiffany A., Carey, Lisa A., Krag, Karen J., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Come, Steven E., Timms, Kirsten M., Hartman, Anne-Renee, Borger, Darrel R., Finkelstein, Dianne M., Garber, Judy E., Ryan, Paula D., Winer, Eric P., Goss, Paul E., Ellisen, Leif W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451173/
https://ncbi.nlm.nih.gov/pubmed/25847936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.57.6660
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados